Shaping the industry


PSI works to shape the industry by promoting good practice for pharmaceutical statisticians in the scientific literature [1, 2], by promoting the value of statistical insight in the development of medicines with our directory of consultants and by lobbying to increase statistical input in regulatory decisions [3].

 

Our regulatory committee reviews and comments on regulatory guidelines on behalf of industry statisticians. Our special interest groups and working parties are forums for statisticians to share experiences and form guidelines for good practice in their specific areas of expertise.

 
PSI is a member of EFSPI, the European federation of national pharmaceutical statistics bodies and participates through EFSPI in Europe-wide industry discussions.

If you wish to contribute to any of these activities, contact chair@psiweb.org.

Latest News


Show all news

EventsFuture Events


  • PSI Journal Club Webinar: Bayesian Methods - Dates: 12 – 12 Jul, 2018

    Our next journal club features two papers on the topic of Bayesian Methods. Please join us to hear Qingzhao Yu (Louisiana State University) and Margaret Gamalo‐Siebers (Eli Lilly & Co) present their recent work.
  • IDEAS Dissemination Workshop - Dates: 26 Sep, 2018

    The aim of the workshop is to translate and promote novel methodologies developed by IDEAS and is geared towards statisticians and trialists with an interest in novel methods for early phase clinical trials. Therefore, it will be of interest to those working in academia, industry, HTA or regulatory authorities.
University of Birmingham Logo

Grade 9 Statistics Lead

read more...

University of Birmingham Logo

Grade 8 Senior Medical Statistician / Epidemiologist

read more...

image002

Head of Biostatistics & Data Management

read more...

PRAHS SQUARE Logo

Biostatistician

read more...

Leeds-80x250

Principal Statistician

read more...

logo_horizontal_large

Principal Biostatistician

read more...